8.19.2024 New drug combos make previously inoperable stomach cancer treatable

The recent application of targeted and immuno-oncology drugs to treat gastric cancer has significantly changed the outcome of inoperable gastric cancer.

In the past, conventional chemotherapy for gastric cancer consisted of only cytotoxic antitumor drugs. Recently, however, it has become possible to add targeted or immuno-oncology drugs to cytotoxic antitumor drugs, depending on the “biomarkers” of gastric cancer tissue